Abstract: In a granular material supply system including a tank that stores granular material, a carrier line through which the granular material flowing out of the tank is carried to a carrier destination, and a cutout line that connects the tank and the carrier line and through which the granular material flowing out of the tank is supplied to the carrier line, a control device includes a density control unit configured to control a density of the granular material on a downstream side of a junction of the cutout line and the carrier line to a set value predetermined and a flow rate control unit configured to control a flow rate of the granular material to be supplied to the carrier destination through the carrier line to a command value instructed by the carrier destination.

Abstract: In a granular material supply system including a tank that stores granular material, a carrier line through which the granular material flowing out of the tank is carried to a carrier destination, and a cutout line that connects the tank and the carrier line and through which the granular material flowing out of the tank is supplied to the carrier line, a control device includes a density control unit configured to control a density of the granular material on a downstream side of a junction of the cutout line and the carrier line to a set value predetermined and a flow rate control unit configured to control a flow rate of the granular material to be supplied to the carrier destination through the carrier line to a command value instructed by the carrier destination.

Abstract: An object of the present invention is to provide a compound that can be used as a more superior therapeutic agent for central nervous system diseases.

Abstract: In the present invention, a coal gasification combined power generation facility comprises: a feed water supply line (72); a condensate pump (39) and an intermediate-pressure feed water pump (40); a turbine bypass line (32) that bypasses a steam turbine and supplies steam to the condenser (73); and a spray water line (76) that supplies the feed water to the turbine bypass line (32). The coal gasification combined power generation facility has a normal operation mode and a bypass operation mode, and in the bypass operation mode, a control device (80) supplies the feed water to the turbine bypass line (32) and performs a first opening degree control to control the opening degree of the supply adjustment valve so that the amount of feed water supplied to the exhaust heat recovery boiler becomes less than that in the normal operation mode.

Abstract: A coal gasification combined power generation facility includes a feed water supply line that supplies feed water condensed by a condenser to an exhaust heat recovery boiler; a supply adjustment valve that adjusts the flow amount of feed water supplied to the exhaust heat recovery boiler; a turbine bypass line that bypasses a steam turbine and supplies steam to the condenser; and a spray water line that supplies the feed water to the turbine bypass line. The coal gasification combined power generation facility has a bypass operation mode, wherein a control device supplies the feed water to the turbine bypass line and performs a first opening degree control to control the opening degree of the supply adjustment valve so that the amount of feed water supplied to the exhaust heat recovery boiler becomes less than that in a normal operation mode.

Abstract: An object of the present invention is to provide a compound that can be used as a more superior therapeutic agent for central nervous system diseases.

Abstract: An object of the present invention is to provide a compound that can be used as a more superior therapeutic agent for central nervous system diseases. The present invention provides a dihydrate of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl) butoxy]-1H-quinolin-2-one or of a salt thereof, and a process for producing the same.

Abstract: An object of the present invention is to provide a compound that can be used as a more superior therapeutic agent for central nervous system diseases. The present invention provides a dihydrate of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or of a salt thereof, and a process for producing the same.

Abstract: An object of the present invention is to provide a compound that can be used as a more superior therapeutic agent for central nervous system diseases. The present invention provides a dihydrate of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or of a salt thereof, and a process for producing the same.

Abstract: An object of the present invention is to provide a compound that can be used as a more superior therapeutic agent for central nervous system diseases. The present invention provides a dihydrate of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or of a salt thereof, and a process for producing the same.

Abstract: An object of the present invention is to provide a compound that can be used as a more superior therapeutic agent for central nervous system diseases. The present invention provides a dihydrate of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or of a salt thereof, and a process for producing the same.

Abstract: A semiconductor device includes an interlayer dielectric film, a passivation film, made of an insulating material, formed on the interlayer dielectric film, an uppermost wire, made of a material mainly composed of copper, formed between the surface of the interlayer dielectric film and the passivation film, and a wire covering film, made of a material mainly composed of aluminum, interposed between the passivation film and the surface of the uppermost wire for covering the surface of the uppermost wire.

Abstract: A semiconductor device includes an interlayer dielectric film, a passivation film, made of an insulating material, formed on the interlayer dielectric film, an uppermost wire, made of a material mainly composed of copper, formed between the surface of the interlayer dielectric film and the passivation film, and a wire covering film, made of a material mainly composed of aluminum, interposed between the passivation film and the surface of the uppermost wire for covering the surface of the uppermost wire.

Abstract: Disclosed is a pharmaceutical composition comprising a ribonucleoside analogue in accordance with general formula I or II as herein defined, in admixture with a physiologically acceptable excipient diluent or carrier.

Abstract: Disclosed is a pharmaceutical composition comprising a ribonucleoside analogue in accordance with general formula (I) or (II) as herein defined in admixture with a physiologically acceptable excipient diluent or carrier.

Abstract: Disclosed is a pharmaceutical composition comprising a ribonucleoside analogue in accordance with general formula I or II as herein defined, in admixture with a physiologically acceptable excipient diluent or carrier.